Covid-19 Update

Stephen Metcalfe Excerpts
Monday 15th November 2021

(2 years, 5 months ago)

Commons Chamber
Read Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Sajid Javid Portrait Sajid Javid
- View Speech - Hansard - - - Excerpts

The hon. Gentleman speaks with great experience on this issue and has talked about it many times in this House. He is right to link this to long covid. I hope I can reassure him. Work is going on in the NHS, in the Department and in some of the research institutes on long covid, which the Government are supporting with millions of pounds, and the NHS is working with people who are suffering from long covid, listening to them about what more we can do.

Stephen Metcalfe Portrait Stephen Metcalfe (South Basildon and East Thurrock) (Con)
- View Speech - Hansard - -

Last week, while I was on a school visit, I was shocked to hear about the extraordinary abuse a headteacher had experienced from parents opposed to in-school vaccination clinics. I am glad to hear that we are making progress on getting 12 to 15-year-olds vaccinated, but will my right hon. Friend join me in encouraging schools to continue to do this and thank them for all the work they have been doing? Can he also tell me what more we can do to reassure parents and students alike that the vaccine is safe, effective and to all our benefit?

Sajid Javid Portrait Sajid Javid
- View Speech - Hansard - - - Excerpts

That is such an important issue in respect of the safety and efficacy of the vaccine. One of the strongest reassurances we can give to everyone is that the decision about whether this vaccine, or any vaccine, is safe and effective is made independently of the Government and Ministers by world-leading clinicians in our independent regulator, the MHRA. They look at the very best evidence available and continue to monitor the data and information. As I mentioned in my statement, when it comes to the vaccination of, for example, 16 and 17-year-olds, one reason why the JCVI was very comfortable in recommending to me that we offer a second dose to that cohort was the continuing close working together of clinicians and the MHRA. I hope that helps to reassure my hon. Friend.